Search This Blog

Tuesday, August 6, 2019

Akcea Therapeutics EPS beats by $0.05, beats on revenue

Akcea Therapeutics (NASDAQ:AKCA): Q2 GAAP EPS of -$0.40 beats by $0.05.
Revenue of $26.62M (+45.3% Y/Y) beats by $0.84M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)